D
Quanterix Corporation QTRX
$7.27 $0.385.52% NASDAQ
Recommendation
Prev Close
$6.89
Volume
157,045
Avg Vol (90D)
654,642
Market Cap
$321.84M
Dividend & Yield
--
52-Week Range
$4.05 - $13.01
P/E (TTM)
--
EPS (TTM)
-$2.33
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Quanterix (QTRX, $6.97) RSI Indicator left the overbought zone on December 01, 2025
12/2/2025 - Tickeron - Stocks
Even after rising 26% this past week, Quanterix (NASDAQ:QTRX) shareholders are still down 83% over the past five years
11/27/2025 - Simply Wall St
Quanterix Reaches Analyst Target Price
11/24/2025 - ETF Channel
Quanterix (QTRX, $6.66) RSI Indicator left the overbought zone on November 21, 2025
11/22/2025 - Tickeron - Stocks
Quanterix (QTRX, $6.66) price may drop as it broke higher Bollinger Band on Nov 21, 2025
11/22/2025 - Tickeron - Stocks
Quanterix (QTRX, $5.91) Aroon Indicator entered a Downtrend on November 20, 2025.
11/21/2025 - Tickeron - Stocks
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
11/20/2025 - GuruFocus
Quanterix names Bill Donnelly executive chair
11/20/2025 - The Fly
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
11/20/2025 - Business Wire
Quanterix (QTRX, $5.86) Aroon Indicator entered a Downtrend on November 19, 2025.
11/20/2025 - Tickeron - Stocks
Quanterix (QTRX, $5.86) price may drop as it broke higher Bollinger Band on Nov 19, 2025
11/20/2025 - Tickeron - Stocks
Quanterix Corporation $QTRX Stock Holdings Decreased by Envestnet Asset Management Inc.
11/20/2025 - MarketBeat
QTRX Makes Bullish Cross Above Critical Moving Average
11/19/2025 - Market News Video
Quanterix (QTRX, $5.62) Aroon Indicator entered a Downtrend on November 18, 2025.
11/19/2025 - Tickeron - Stocks
Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for ...
11/17/2025 - GuruFocus
Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
11/17/2025 - Business Wire
Quanterix (QTRX, $5.32) Stochastic Oscillator left the overbought zone on November 13, 2025
11/14/2025 - Tickeron - Stocks
Quanterix (QTRX, $5.22) entered Uptrend as Momentum indicator ascends above 0 level on Nov 12, 2025
11/13/2025 - Tickeron - Stocks
Quanterix (QTRX, $5.01) Stochastic Oscillator left the oversold zone on November 11, 2025
11/12/2025 - Tickeron - Stocks
Quanterix (NASDAQ:QTRX) Issues Quarterly Earnings Results, Misses Estimates By $0.13 EPS
11/11/2025 - MarketBeat
Quanterix Corp (QTRX) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
11/11/2025 - GuruFocus
Q3 2025 Quanterix Corp Earnings Call Transcript
11/11/2025 - GuruFocus
Quanterix Corp Q3 Loss Increases, Misses Estimates
11/11/2025 - Nasdaq News: Markets
Quanterix Corporation (QTRX) Q3 2025 Earnings Call Transcript
11/11/2025 - Seeking Alpha: Transcripts
Quanterix Corporation (QTRX) Q3 2025 Earnings Call Transcript
11/11/2025 - SeekingAlpha
Income Statement
Total Revenue (TTM)
$130.20M
EBITDA (TTM)
-$72.81M
EBIT (TTM)
-$84.15M
Net Income (TTM)
-$95.66M
Balance Sheet
Total Assets (Q)
$444.14M
Total Debt (Q)
$40.12M
Total Liabilities (Q)
$129.61M
Book Value Per Share (Q)
$6.74
Cash Flow
Cash from Operations (TTM)
-$65.09M
Cash from Investing (TTM)
$74.18M
Cash from Financing (TTM)
-$145.00K
Net Change in Cash (TTM)
$9.69M
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Dec 22 and 26 (est)
Price History
Loading...
Beta
1.51
7-Day Total Return
9.16%
30-Day Total Return
19.97%
60-Day Total Return
69.46%
90-Day Total Return
12.02%
Year to Date Total Return
-32.44%
1-Year Total Return
-38.29%
2-Year Total Return
-70.50%
3-Year Total Return
-44.08%
5-Year Total Return
-83.54%
52-week Low
May 14, 2025 - $4.05
52-week High
Dec 04, 2024 - $13.01
Valuation
Market Cap
$321.84M - Small Cap
Enterprise Value
$227.15M
Price/Sales (TTM)
2.44
Price/Book (Q)
1.02
Dividends and Shares
Shares Outstanding
46.06
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.quanterix.com
Phone Number
617 301 9400
Address
Building 1
Billerica, MA 01821
Country
United States
Year Founded
2007
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in... more
NASDAQ 12/03/2025 10:58AM Eastern Quotes delayed